feed,title,long_url,short_url
TMF,Vir Biotechnology and GSK Launch Phase 2/3 Study of COVID-19 Antibody,https://www.fool.com/investing/2020/08/31/vir-biotechnology-and-gsk-launch-phase-23-study-of/?source=iedfolrf0000001,https://j.mp/3hM2mzl
